| Code | Description | Claims | Beneficiaries | Total Paid |
| T1015 |
Clinic visit/encounter, all-inclusive |
60,002 |
50,613 |
$5.23M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
75,961 |
44,471 |
$1.61M |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
25,830 |
10,622 |
$287K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
9,375 |
5,610 |
$262K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
6,077 |
3,682 |
$177K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
5,742 |
3,416 |
$149K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
5,093 |
3,071 |
$146K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
3,682 |
2,245 |
$120K |
| G0467 |
Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit |
2,654 |
2,345 |
$72K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
9,969 |
5,656 |
$62K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
3,937 |
2,273 |
$51K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,861 |
1,661 |
$51K |
| 87428 |
|
2,689 |
1,422 |
$45K |
| 90832 |
Psychotherapy, 30 minutes with patient |
613 |
313 |
$14K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
170 |
133 |
$13K |
| 90791 |
Psychiatric diagnostic evaluation |
147 |
111 |
$11K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
507 |
466 |
$7K |
| 90686 |
|
5,619 |
3,372 |
$7K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
492 |
343 |
$5K |
| 90670 |
|
3,603 |
2,276 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
375 |
140 |
$2K |
| 0011A |
|
51 |
51 |
$2K |
| 99381 |
|
86 |
65 |
$2K |
| 90715 |
|
156 |
126 |
$2K |
| 0012A |
|
44 |
44 |
$2K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
37 |
26 |
$1K |
| 96127 |
|
556 |
326 |
$1K |
| 90698 |
|
2,552 |
1,572 |
$1K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
178 |
127 |
$1K |
| 99173 |
|
656 |
385 |
$788.05 |
| 81002 |
|
734 |
484 |
$786.95 |
| 90651 |
|
1,229 |
789 |
$629.33 |
| 92551 |
|
206 |
113 |
$611.35 |
| 85018 |
|
604 |
332 |
$540.45 |
| 90680 |
|
1,407 |
887 |
$530.00 |
| 90656 |
|
138 |
138 |
$503.00 |
| 0071A |
|
13 |
13 |
$493.74 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
103 |
53 |
$367.50 |
| 90744 |
|
821 |
530 |
$352.04 |
| 90734 |
|
444 |
264 |
$343.34 |
| 90785 |
|
57 |
31 |
$335.08 |
| 90710 |
|
269 |
144 |
$296.00 |
| 90633 |
|
1,236 |
778 |
$280.00 |
| 81003 |
|
261 |
140 |
$191.54 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
26 |
12 |
$137.16 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
45 |
28 |
$133.12 |
| 90685 |
|
262 |
204 |
$130.00 |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
28 |
26 |
$128.42 |
| 81025 |
|
13 |
12 |
$72.07 |
| 90696 |
|
172 |
92 |
$60.50 |
| 90700 |
|
65 |
39 |
$30.00 |
| 3044F |
|
63 |
37 |
$20.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
108 |
64 |
$7.97 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
26 |
12 |
$0.44 |
| 4004F |
|
17,777 |
10,243 |
$0.00 |
| 1159F |
|
24,796 |
13,390 |
$0.00 |
| G8783 |
Normal blood pressure reading documented, follow-up not required |
15,304 |
8,416 |
$0.00 |
| 1160F |
|
24,800 |
13,391 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
36,404 |
33,128 |
$0.00 |
| 3078F |
|
16,377 |
9,033 |
$0.00 |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
2,250 |
1,436 |
$0.00 |
| G8506 |
Patient receiving angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy |
3,213 |
1,950 |
$0.00 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
1,018 |
678 |
$0.00 |
| 90671 |
|
542 |
327 |
$0.00 |
| 3077F |
|
199 |
107 |
$0.00 |
| 3015F |
|
1,002 |
537 |
$0.00 |
| 3050F |
|
195 |
125 |
$0.00 |
| 90648 |
|
37 |
26 |
$0.00 |
| 90380 |
|
15 |
12 |
$0.00 |
| 90707 |
|
23 |
12 |
$0.00 |
| G8753 |
Most recent systolic blood pressure >= 140 mmhg |
27 |
26 |
$0.00 |
| 3017F |
|
1,335 |
713 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
21,196 |
17,527 |
$0.00 |
| 3074F |
|
18,075 |
9,913 |
$0.00 |
| 1036F |
|
23,717 |
13,892 |
$0.00 |
| 3048F |
|
3,005 |
1,806 |
$0.00 |
| 1125F |
|
2,109 |
1,298 |
$0.00 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
1,128 |
769 |
$0.00 |
| 4010F |
|
1,030 |
547 |
$0.00 |
| H0049 |
Alcohol and/or drug screening |
3,890 |
2,066 |
$0.00 |
| 3079F |
|
3,021 |
1,650 |
$0.00 |
| 3075F |
|
647 |
342 |
$0.00 |
| 1126F |
|
3,004 |
1,799 |
$0.00 |
| G9226 |
Foot examination performed (includes examination through visual inspection, sensory exam with 10-g monofilament plus testing any one of the following: vibration using 128-hz tuning fork, pinprick sensation, ankle reflexes, or vibration perception threshold, and pulse exam; report when all of the 3 components are completed) |
210 |
118 |
$0.00 |
| 3008F |
|
26,429 |
14,590 |
$0.00 |
| 3049F |
|
901 |
509 |
$0.00 |
| 3080F |
|
130 |
71 |
$0.00 |
| 90619 |
|
134 |
73 |
$0.00 |
| G8755 |
Most recent diastolic blood pressure >= 90 mmhg |
26 |
26 |
$0.00 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
15 |
13 |
$0.00 |
| 3014F |
|
72 |
36 |
$0.00 |